Topic Market manipulation ChroMedX Corp.: BaFin warns of buy recommendations for shares

Date: 07.12.2017

According to information available to the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht – BaFin), buy recommendations are currently being issued for shares in ChroMedX Corp. (ISIN CA17111W1095) on a large scale via e-mail newsletters.

BaFin has evidence indicating that these buy recommendations contain false or misleading information and/or that existing conflicts of interest are wrongfully concealed. It has initiated an investigation into suspected market manipulation in the share.

BaFin therefore recommends all investors to closely examine whether the information provided is reliable and to obtain information about the company in question from other sources prior to buying the shares.

Did you find this article helpful?

We appreciate your feedback

* Mandatory field